Titan Medical Inc. Ordinary Shares
TMDI
TMDI was delisted on the 9th of March, 2023.
44 hedge funds and large institutions have $1.96M invested in Titan Medical Inc. Ordinary Shares in 2020 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 13 increasing their positions, 5 reducing their positions, and 14 closing their positions.
160% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 5
2.9% less ownership
Funds ownership: 6.43% → 3.53% (-2.9%)
15% less funds holding
Funds holding: 52 → 44 (-8)
54% less capital invested
Capital invested by funds: $4.23M → $1.96M (-$2.27M)
57% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Advisers
New York
|
+$58.2K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$48.3K |
| 3 |
Morgan Stanley
New York
|
+$32.5K |
| 4 |
JP Morgan Chase
New York
|
+$23.4K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$21.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$1.97M |
| 2 |
Bank of New York Mellon
New York
|
-$67K |
| 3 |
LSA
L & S Advisors
Los Angeles,
California
|
-$42K |
| 4 |
VFA
Valeo Financial Advisors
Carmel,
Indiana
|
-$39.6K |
| 5 |
Renaissance Technologies
New York
|
-$29K |
TMDI Hedge Fund Activity: Q3 2020 in Review
44 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in Titan Medical Inc. Ordinary Shares (TMDI) for Q3 2020, worth a combined $1.96M — down 54% from $4.23M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of TMDI and 6 opened new positions — a net loss of 8 holders — while 5 trimmed existing stakes and 13 added.
The largest buyer was Two Sigma Advisers, adding an estimated $58.2K. The largest seller was Armistice Capital, exiting entirely with an estimated $1.97M sold.
- 44 institutional investors held Titan Medical Inc. Ordinary Shares (TMDI) as of Q3 2020, down from 52 in Q2 2020.
- Funds reported $1.96M of Titan Medical Inc. Ordinary Shares stock for Q3 2020, down 54% quarter-over-quarter.
- 6 funds opened new Titan Medical Inc. Ordinary Shares positions in Q3 2020 and 14 closed out, a net change of -8 holders.
- The largest Titan Medical Inc. Ordinary Shares buyer in Q3 2020 was Two Sigma Advisers, an estimated $58.2K added.
- The largest Titan Medical Inc. Ordinary Shares seller in Q3 2020 was Armistice Capital, an estimated $1.97M sold.
Based on aggregated 13F filings for Q3 2020.